Company: SNSE
Filing Date: 2025-01-07
Form Type: 8-K
Source: 0001193125-25-002920
Chunk: 0

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-01-07
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

As previously disclosed on a Current Report on Form8-Kfiled by Sensei Biotherapeutics, Inc. (the “ Company”) on July 12, 2024, on July 10, 2024, the Company received a letter from the Listing Qualifications Staff (the “ Staff”) of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that for the previous 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until January 6, 2025, to regain compliance with the minimum bid price requirement. As of the date of this Current Report on Form8-K, the Company’s common stock has not regained compliance with the minimum bid price requirement.